Clinical Trial Update: Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1 [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Pertuzumab-Herceptin vs Pertuzumab-Herceptin with metronomic chemotherapy, followed by T-DM1 in elderly patients with metastatic breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Elderly Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Pertuzumab (pertuzumab)
• T-DM1 (ado-trastuzumab emtansine)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Elderly Metastatic Breast Cancer Population | Phase 2 | Status: COMPLETED